Acetaminophen, gabapentin

Phase 3Small molecule

Acetaminophen, gabapentin is one of 15 small molecule programs targeting Respiratory Depression. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Respiratory DepressionActive, not recruiting

Respiratory DepressionPhase 3

Active, not recruiting

Competition

Competitive Landscape

26 competitors in Respiratory Depression

#DrugCompanyPhaseTrials

Narcan

SScienture

Approved

2 2

Anerem

AAcacia Pharma Ltd

Approved

1 3

Duragesic

CCephalon

Approved

1 4

MS Contin

HHikma Pharmaceuticals LLC

Selincro

1 6

Tylenol

KKenvue Brands

Phase 3

1 7

Prozac

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 2

1 8

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 1

3 9

Fentanyl, Dexmedetomidine

UUniversity of Saskatchewan

Phase 3

1 10

Acetaminophen, gabapentin

UUniversity of Saskatchewan

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Opioid Free Anesthesia1 trial

Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery

Unknown status·UUniversity of Saskatchewan·Phase 3·NCT04144933·60 enrolled

Respiratory Depression1 trial

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy

Completed·UUniversity of Saskatchewan·Phase 3·NCT02987985·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Acetaminophen, gabapentin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Acetaminophen, gabapentin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Acetaminophen, gabapentin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Saskatchewan company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of Saskatchewan

Acetaminophen, gabapentin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Opioid Free Anesthesia1 trial

Respiratory Depression1 trial

References

Drug Info

Quick Facts

Related News